JW saw the highest growth of 99% in patent filings and 66% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 99% and grants by 66%. GlobalData’s DataBook provides a comprehensive analysis of JW’s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

JW has been focused on protecting inventions in South Korea(KR) with three publications in Q4 2023

The South Korea(KR) Patent Office dominates the patent filings and grants with nearly 100% filings and 67% grants. The South Korea(KR), and Canada(CA) patent Office are among the top ten patent offices where JW is filings its patents. Among the top granted patent authorities, JW has 67% of its grants in South Korea(KR) and 33% in Canada(CA).

Chronic kidney disease (chronic renal failure) related patents lead JW portfolio followed by renal insufficiency, and renal stones/calculi

JW has highest number of patents in chronic kidney disease (chronic renal failure) followed by renal insufficiency, renal stones/calculi, gouty arthritis (gout).

For comprehensive analysis of JW's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.